Exact Mass: 664.4128

Phytolaccasaponin G

C36H56O11 (664.3822)

From Phytolacca americana (pokeberry). Phytolaccasaponin G is found in fruits, green vegetables, and american pokeweed. Phytolaccasaponin G is found in american pokeweed. Phytolaccasaponin G is from Phytolacca americana (pokeberry

Medicagenic acid 3-O-beta-D-glucoside

C36H56O11 (664.3822)

Medicagenic acid 3-O-beta-D-glucoside is found in cereals and cereal products. Medicagenic acid 3-O-beta-D-glucoside is isolated from the roots of Medicago sativa (alfalfa Isolated from the roots of Medicago sativa (alfalfa). Medicagenic acid 3-O-beta-D-glucoside is found in cereals and cereal products.

3-O-trans-Feruloyleuscaphic acid

C40H56O8 (664.3975)

3-O-trans-Feruloyleuscaphic acid is found in fruits. 3-O-trans-Feruloyleuscaphic acid is a constituent of Eriobotrya japonica (loquat) Constituent of Eriobotrya japonica (loquat). 3-O-trans-Feruloyleuscaphic acid is found in fruits.

Elatoside G

C36H56O11 (664.3822)

Elatoside G is found in green vegetables. Elatoside G is a constituent of Aralia elata (Japanese angelica tree). Constituent of Aralia elata (Japanese angelica tree). Elatoside G is found in green vegetables.

PA(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))

C37H61O8P (664.4104)

PA(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of eicosapentaenoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))

C37H61O8P (664.4104)

PA(20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z)), in particular, consists of one chain of eicosapentaenoic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

Paliperidone Palmitate

C39H57FN4O4 (664.4364)

PA(10:0/PGF1alpha)

C33H61O11P (664.3951)

PA(10:0/PGF1alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/PGF1alpha), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of Prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGF1alpha/10:0)

C33H61O11P (664.3951)

PA(PGF1alpha/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGF1alpha/10:0), in particular, consists of one chain of one Prostaglandin F1alpha at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(13:0/18:1(12Z)-2OH(9,10))

C34H65O10P (664.4315)

PA(13:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(13:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one tridecanoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/13:0)

C34H65O10P (664.4315)

PA(18:1(12Z)-2OH(9,10)/13:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/13:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of tridecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(a-13:0/18:1(12Z)-2OH(9,10))

C34H65O10P (664.4315)

PA(a-13:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(a-13:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one 10-methyldodecanoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/a-13:0)

C34H65O10P (664.4315)

PA(18:1(12Z)-2OH(9,10)/a-13:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/a-13:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of 10-methyldodecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(i-13:0/18:1(12Z)-2OH(9,10))

C34H65O10P (664.4315)

PA(i-13:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-13:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one 11-methyldodecanoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/i-13:0)

C34H65O10P (664.4315)

PA(18:1(12Z)-2OH(9,10)/i-13:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/i-13:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of 11-methyldodecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

IlexsaponinA

C36H56O11 (664.3822)

Ilexsaponin A1 is a natural product found in Ilex pubescens and Mussaenda pubescens with data available. Ilexsaponin A, isolated from the root of Ilex pubescens, attenuates ischemia-reperfusion-induced myocardial injury through anti-apoptotic pathway. Ilexsaponin A can reduce myocardial infarct size, lower the serum levels of LDH, AST and CK-MB, increase cellular viability and inhibit apoptosis in hypoxia/reoxygenation cardiomyocytes[1].

Quadranoside VII

C36H56O11 (664.3822)

Gagunin I

C36H56O11 (664.3822)

Quadranoside VI

C36H56O11 (664.3822)

Quadranoside V

C36H56O11 (664.3822)

Beesioside M

C37H60O10 (664.4186)

Rubuside J

C36H56O11 (664.3822)

Beesioside F

C37H60O10 (664.4186)

Laetiposide F

C37H60O10 (664.4186)

Eryloside R

C38H64O9 (664.455)

paradrymonoside

C36H56O11 (664.3822)

gagunin C

C36H56O11 (664.3822)

gagunin P

C36H56O11 (664.3822)

Bisandrographolide B

C40H56O8 (664.3975)

Ilexsaponin A1

C36H56O11 (664.3822)

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-butanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] 14-hydroxytetradecanoate

C32H56O14 (664.367)

(24R)-24-O-alpha-D-glucopyranosyl-27-nor-5alpha-cholestane-3beta,4beta,5,6alpha,7beta,8,14,15alpha,24-nonaol|typicusoside A

C32H56O14 (664.367)

microtropioside C

C32H56O14 (664.367)

Bisandrographolide A

C40H56O8 (664.3975)

25-O-methylcimigenol-3-O-beta-D-galactopyranoside

C37H60O10 (664.4186)

gagunin O

C36H56O11 (664.3822)

Squarroside A1

C37H60O10 (664.4186)

Urolsaeure-3-benzoat-benzoesaeureanhydrid

C44H56O5 (664.4128)

O21-Ac-Bafilomycin A1

C37H60O10 (664.4186)

32-butan-2-yl-14,16,18,20,22,24,26,28-octahydroxy-15,31-dimethyl-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C37H60O10 (664.4186)

microtropioside D

C32H56O14 (664.367)

(+)-2alpha,16beta,31-triacetyl-9,11-dihydrobuxiran

C39H56N2O7 (664.4087)

3beta,29-dihydroxyolean-12-ene-24,28-dioic acid 28-O-beta-glucopyranoside|ilexhainanoside E

C36H56O11 (664.3822)

(1S,2S,4R,9beta,16alpha)-1,16,20-trihydroxy-9,10,14-trimethyl-11,22-dioxo-4,9-cyclo-9,10-secocholesta-5,25-dien-2-yl beta-D-glucopyranoside|2beta,3alpha,16alpha,20beta-tetrahydroxycucurbita-5,25-diene-11,22-dion-2-yl beta-D-glucopyranoside|xuedanglycoside B

C36H56O11 (664.3822)

2beta-Glucosyloxy-16alpha,20,22-trihydroxy-9beta-methyl-19-norlanosta-5,24-diene-3,11-dione

C36H56O11 (664.3822)

digitoxigenin 3-O-beta-digitalopyranosyl-(1->4)-O-beta-digitoxopyranoside|madagascarensilide B

C36H56O11 (664.3822)

21-O-beta-D-xylopyranosyl-18S-hydroxydihydroprotolichesterinate 21-O-beta-D-glucopyranoside

C32H56O14 (664.367)

MCULE-1470692437

C36H56O11 (664.3822)

(3alpha)-3,29-dihydroxy-7-oxomultiflor-8-ene-3,29-diyl dibenzoate|(3alpha)-7-oxomultiflor-8-ene-3,29-diol 3,29-dibenzoate

C44H56O5 (664.4128)

dammar-24-en-3beta,11alpha,20(S)-triol 3-O-beta-D-2-O-acetylglucopyranoside

C38H64O9 (664.455)

(2beta,9beta,10alpha,16alpha,20beta,24Z)-2-(beta-D-glucopyranosyloxy)-16,20,26-trihydroxy-9-methyl-19-norlanost-5,24-diene-3,11-dione

C36H56O11 (664.3822)

tormentic acid 6-methoxy-beta-D-glucopyranosyl ester|Tormentic acid-6-methoxy ??-D-glucopyranosyl ester

C37H60O10 (664.4186)

(23E)-(12R,20S)-12,20-dihydroxy-25-methoxy-3,4-secodammara-4(28),23-dien-3-oic acid ethyl ester 12-O-alpha-L-arabinopyranoside|cyclocarioside G

C38H64O9 (664.455)

laevigin C

C36H56O11 (664.3822)

(1R)-1,4-epoxy-22alpha-hydroxy-3,4-seco-lup-20(30)-ene-3,28-dioic acid 28-O-beta-D-glucopyranoside|acanthosessilioside E

C36H56O11 (664.3822)

3beta,19alpha-dihydroxyurs-12-en-24,28-dioic aicd 24-O-beta-D-glucopyranosyl ster|ilexsaponin B

C36H56O11 (664.3822)

multiflora-7,9(11)-diene-3alpha,29-diol 3-p-hydroxybenzoate-29-benzoate

C44H56O5 (664.4128)

methyl (1E,5S,9R,10S,12Z,14aS,17S,21R,24S,26aS,26bS)-3,5,8,9,10,11,14a,15,16,17,18,19,20,21,22,23,24,25,26,26b-icosahydro-10-hydroxy-2,6,10,13,17,21-hexamethyl-15,22,25-trioxo-24-(propan-2-yl)-5,9-epoxybenzo[1,2-a:3,4-a?]di[14]annulene-26a(4H)-carboxylate|sarcophytolide J

C41H60O7 (664.4339)

Rosamultin

C37H60O10 (664.4186)

HUYA-1

C37H60O10 (664.4186)

3-O-beta-D-(2-O-acetyl)-xylopyranosyl-20S,24R-epoxycycloartan-3beta,6alpha,16beta,25-tetraol

C37H60O10 (664.4186)

16-O-beta-D-glucopyranosyl-20(S),24(R)-5alpha,9-diepoxy-2alpha,3beta,16beta,25-tetrahydroxy-9,10-seco-cycloarta-1(10),6(7)-diene|prusianoside A

C36H56O11 (664.3822)

3-Ketone,2-O-beta-D-glucopyranoside-(2beta, 3beta,16alpha,20S,24Z)-2,3,16,20,26-Pentahydroxycucurbita-5,24-diene-11-one

C36H56O11 (664.3822)

3-O-beta-D-glucuronopyranosyl ilexosapogenin A|ilexoside XXXII

C36H56O11 (664.3822)

26-Deoxy,3-Ketone,2-O-beta-D-Glucopyranoside-(2beta,3beta,16alpha,20(,24(,25()-20,24-Epoxy-2,3,16,25,26-pentahydroxycucurbit-5-en-11-one|26-Deoxy,3-Ketone,2-O-beta-D-Glucopyranoside-(2beta,3beta,16alpha,20xi,24xi,25xi)-20,24-Epoxy-2,3,16,25,26-pentahydroxycucurbit-5-en-11-one

C36H56O11 (664.3822)

Cyclogaleginoside A

C37H60O10 (664.4186)

C40H56O8

C40H56O8 (664.3975)

C36H56O11

C36H56O11 (664.3822)

Sarmentogenin-cymarosido-digitoxosid

C36H56O11 (664.3822)

NSTX-3

C30H52N10O7 (664.402)

16-alpha-hydroxygypsogenate-28-beta-D-glucoside

C36H56O11 (664.3822)

28-O-beta-D-glucopyranosyl-2alpha,3beta-dihydroxyolean-12-ene-24,28-dioic acid|28-O-??-D-Glucopyranosyl-2??-3??-dihydroxyolean-12-ene-24,28-dioic acid|chaenomeloside A

C36H56O11 (664.3822)

(22S)-cholest-5-ene-3beta,11alpha,16beta,22-tetrol 16-O-(2,3-di-O-acetyl-alpha-L-rhamnopyranoside)|(22S)-Cholest-5-ene-3??,11??,16??,22-tetrol 16-O-(2,3-di-O-acetyl-??-L-rhamnopyranoside)

C37H60O10 (664.4186)

2beta,3beta-dihydroxy-16-O-beta-D-glucopyranosyl-24alpha-formyl-olean-12-en-28-oic acid

C36H56O11 (664.3822)

C38H64O9

C38H64O9 (664.455)

ilexoside XLII

C36H56O11 (664.3822)

C40H56O6S

C40H56O6S (664.3797)

Periplogenin-cymarosido-digitoxosid

C36H56O11 (664.3822)

Myxoxanthophyll

C41H60O7 (664.4339)

3-O-beta-D-glucuronopyranosylbayogenin|caryocaroside III-5

C36H56O11 (664.3822)

Dianoside F

C36H56O11 (664.3822)

Arjunglucoside III

C36H56O11 (664.3822)

His Leu Val Leu Arg

C31H56N10O6 (664.4384)

3-decanoyl-3,4-di(3-methylbutanoyl)sucrose

C32H56O14 (664.367)

medicagenate-23-O-beta-D-glucoside

C36H56O11 (664.3822)

Ilexhainanoside D

C36H56O11 (664.3822)

3-[4-[5-(acetyloxymethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-(2,5-dihydroxy-6-methylhept-6-en-2-yl)-6,9a,9b-trimethyl-7-prop-1-en-2-yl-1,2,3,3a,4,5,5a,7,8,9-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C37H60O10 (664.4186)

(2S,3S,9R,13R,14S,16R)-2,16-dihydroxy-17-[(2R)-2-hydroxy-6-methyl-3-oxohept-6-en-2-yl]-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one

C36H56O11 (664.3822)

C37H60O10

C37H60O10 (664.4186)

C36H56O11_1-O-[(2alpha,3beta,19alpha)-2,3,19-Trihydroxy-24,28-dioxoolean-12-en-28-yl]-beta-D-glucopyranose

C36H56O11 (664.3822)

phytolaccosideb

C36H56O11 (664.3822)

C36H56O11_Hexopyranose, 1-O-(3,19,23-trihydroxy-23,28-dioxoolean-12-en-28-yl)

C36H56O11 (664.3822)

C36H56O11_Hexopyranose, 1-O-[(3beta,5xi,9xi,18xi)-3,19,24-trihydroxy-24,28-dioxours-12-en-28-yl]

C36H56O11 (664.3822)

11-hydroxy-9-(hydroxymethyl)-2-methoxycarbonyl-2,6a,6b,9,12a-pentamethyl-10-(3,4,5-trihydroxyoxan-2-yl)oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H56O11 (664.3822)

(3S,4R,6aR,6bS,8aS,11R,12R,14bR)-3,12-dihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

Medicagenic acid base + O-Hex

C36H56O11 (664.3822)

Annotation level-3

Cyclogaleginoside A.

C37H60O10 (664.4186)

Origin: Plant; SubCategory_DNP: Triterpenoids

(2S,3S,9R,13R,14S,16R)-2,16-dihydroxy-17-[(2R)-2-hydroxy-6-methyl-3-oxohept-6-en-2-yl]-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one [IIN-based: Match]

C36H56O11 (664.3822)

11-hydroxy-9-(hydroxymethyl)-2-methoxycarbonyl-2,6a,6b,9,12a-pentamethyl-10-(3,4,5-trihydroxyoxan-2-yl)oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid_major

C36H56O11 (664.3822)

legonoxamine H

C32H52N6O9 (664.3796)

LYRIT

C31H52N8O8 (664.3908)

Caloxanthin sulfate

C40H56O6S (664.3797)

Prostaglandin F2α-biotin

C35H60N4O6S (664.4233)

PG(12:0/16:1(9Z))

C34H65O10P (664.4315)

PG(13:0/15:1(9Z))

C34H65O10P (664.4315)

PG(14:0/14:1(9Z))

C34H65O10P (664.4315)

PG(14:1(9Z)/14:0)

C34H65O10P (664.4315)

PG(15:1(9Z)/13:0)

C34H65O10P (664.4315)

PG(16:1(9Z)/12:0)

C34H65O10P (664.4315)

PA(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))

C37H61O8P (664.4104)

PA(20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))

C37H61O8P (664.4104)

PA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/12:0)

C37H61O8P (664.4104)

PA(12:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

C37H61O8P (664.4104)

3-O-trans-Feruloyleuscaphic acid

C40H56O8 (664.3975)

Compound g2

C36H56O11 (664.3822)

Elatoside G

C36H56O11 (664.3822)

PG 28:1

C34H65O10P (664.4315)

PA 34:6

C37H61O8P (664.4104)

OON-PG

C33H61O11P (664.3951)

Lehmanniaside

C37H60O10 (664.4186)

Paliperidone Palmitate

C39H57FN4O4 (664.4364)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Paliperidone palmitate (9-Hydroxyrisperidone palmitate), an atypical long-acting antipsychotic agent, is an ester proagent of Paliperidone. Paliperidone is a dopamine antagonist and 5-HT2A antagonist of the atypical antipsychotic class. Paliperidone palmitate shows efficacy against schizophrenia[1].

Bisandrographolide C

C40H56O8 (664.3975)

1,11-dihydroxy-10-[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid

C40H56O8 (664.3975)

Medicagenic acid 3-glucoside

C36H56O11 (664.3822)

3-Decanoyl-3,4-di(isovaleryl)sucrose

C32H56O14 (664.367)

myristoyl-D-asparaginyl-butan-2-aminyl-malonyl-1-aminocyclopropane-1-carboxyl-acetyl-glycine

C33H54N5O9- (664.3921)

(3S,4S,6aR,6bS,8aR,14bR)-3,8-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-8a-[(3S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

[(2R)-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-phosphonooxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C37H61O8P (664.4104)

(4aS,6aR,6aS,6bR,8aR,9S,10R,11S,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H56O11 (664.3822)

PA(10:0/PGF1alpha)

C33H61O11P (664.3951)

PA(PGF1alpha/10:0)

C33H61O11P (664.3951)

PA(13:0/18:1(12Z)-2OH(9,10))

C34H65O10P (664.4315)

PA(18:1(12Z)-2OH(9,10)/13:0)

C34H65O10P (664.4315)

PA(a-13:0/18:1(12Z)-2OH(9,10))

C34H65O10P (664.4315)

PA(18:1(12Z)-2OH(9,10)/a-13:0)

C34H65O10P (664.4315)

PA(i-13:0/18:1(12Z)-2OH(9,10))

C34H65O10P (664.4315)

PA(18:1(12Z)-2OH(9,10)/i-13:0)

C34H65O10P (664.4315)

(R)-paliperidone palmitate

C39H57FN4O4 (664.4364)

1-Palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine(1-)

C33H63NO10P- (664.4189)

An anionic phospholipid that is the conjugate base of 1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine, obtained by deprotonation of the free carboxy group; major species at pH 7.3.

(2S,4aR,6aR,6aS,6bR,8aR,9R,10R,11S,12aR,14bS)-11-hydroxy-9-(hydroxymethyl)-2-methoxycarbonyl-2,6a,6b,9,12a-pentamethyl-10-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H56O11 (664.3822)

(S)-paliperidone palmitate

C39H57FN4O4 (664.4364)

(2S,3S,9R,13R,14S,16R)-2,16-dihydroxy-17-[(2R)-2-hydroxy-6-methyl-3-oxohept-6-en-2-yl]-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one

C36H56O11 (664.3822)

O-[1-O-Palmitoyl-2-O-(5,8-dioxo-8-hydroxy-6-octenoyl)-L-glycero-3-phospho]choline

C32H59NO11P+ (664.3826)

(Z)-17-[(2R,3R,4S,5S,6R)-3-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-9-enoic acid

C32H56O14 (664.367)

2-[[2-[(E)-7-carboxy-5-oxohept-6-enoyl]oxy-3-hexadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H59NO11P+ (664.3826)

(3S,4S,4aR,6aR,6bS,8R,8aR,12aS,14aR,14bR)-3,8-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-8a-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

CID 45783224

C36H56O11 (664.3822)

3-[4-[5-(Acetyloxymethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-(2,5-dihydroxy-6-methylhept-6-en-2-yl)-6,9a,9b-trimethyl-7-prop-1-en-2-yl-1,2,3,3a,4,5,5a,7,8,9-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C37H60O10 (664.4186)

Mgdg O-9:0_20:5

C38H64O9 (664.455)

Mgdg O-24:5_5:0

C38H64O9 (664.455)

Mgdg O-26:5_3:0

C38H64O9 (664.455)

Mgdg O-22:5_7:0

C38H64O9 (664.455)

Mgdg O-20:5_9:0

C38H64O9 (664.455)

Mgdg O-16:4_13:1

C38H64O9 (664.455)

Mgdg O-13:1_16:4

C38H64O9 (664.455)

Mgdg O-18:5_11:0

C38H64O9 (664.455)

Mgdg O-11:0_18:5

C38H64O9 (664.455)

PE-Cer 19:2;2O/16:4

C37H65N2O6P (664.458)

PE-Cer 13:1;2O/22:5

C37H65N2O6P (664.458)

PE-Cer 19:3;2O/16:3

C37H65N2O6P (664.458)

PE-Cer 15:3;2O/20:3

C37H65N2O6P (664.458)

PE-Cer 13:0;2O/22:6

C37H65N2O6P (664.458)

PE-Cer 17:1;2O/18:5

C37H65N2O6P (664.458)

PE-Cer 17:3;2O/18:3

C37H65N2O6P (664.458)

PE-Cer 17:2;2O/18:4

C37H65N2O6P (664.458)

PE-Cer 15:2;2O/20:4

C37H65N2O6P (664.458)

PE-Cer 15:1;2O/20:5

C37H65N2O6P (664.458)

PE-Cer 13:2;2O/22:4

C37H65N2O6P (664.458)

[(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H65N2O6P (664.458)

[(E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H65N2O6P (664.458)

[(4E,8E,12E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxyhexadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H65N2O6P (664.458)

[(4E,8E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H65N2O6P (664.458)

[(E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxydec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H65N2O6P (664.458)

[(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H65N2O6P (664.458)

[(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H65N2O6P (664.458)

[(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H65N2O6P (664.458)

[2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H65N2O6P (664.458)

[(4E,8E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H65N2O6P (664.458)

PMeOH 15:1_18:5

C37H61O8P (664.4104)

PEtOH 14:1_18:5

C37H61O8P (664.4104)

PMeOH 13:1_20:5

C37H61O8P (664.4104)

PEtOH 16:3_16:3

C37H61O8P (664.4104)

PEtOH 16:2_16:4

C37H61O8P (664.4104)

PMeOH 17:2_16:4

C37H61O8P (664.4104)

[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C37H60O10 (664.4186)

[1-octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C37H60O10 (664.4186)

[1-decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C37H60O10 (664.4186)

[3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H65N2O6P (664.458)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-tetracos-13-enoate

C34H65O10P (664.4315)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-docos-13-enoate

C34H65O10P (664.4315)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-nonadec-9-enoate

C34H65O10P (664.4315)

[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-hexacos-15-enoate

C34H65O10P (664.4315)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-icos-11-enoate

C34H65O10P (664.4315)

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-henicos-11-enoate

C34H65O10P (664.4315)

[1-[(2-dodecanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-hexadec-9-enoate

C34H65O10P (664.4315)

[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] tetradecanoate

C34H65O10P (664.4315)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-undecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-heptadec-9-enoate

C34H65O10P (664.4315)

[1-[(2-decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-octadec-9-enoate

C34H65O10P (664.4315)

[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] pentadecanoate

C34H65O10P (664.4315)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-tridecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-pentadec-9-enoate

C34H65O10P (664.4315)

Isodiotigenin-tri-trimethylsilyl ether

C36H68O5Si3 (664.4374)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (Z)-henicos-11-enoate

C34H65O10P (664.4315)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (Z)-icos-11-enoate

C34H65O10P (664.4315)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-nonadec-9-enoate

C34H65O10P (664.4315)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (Z)-docos-13-enoate

C34H65O10P (664.4315)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-tetracos-13-enoate

C34H65O10P (664.4315)

[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-hexacos-15-enoate

C34H65O10P (664.4315)

[1-phosphonooxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C37H61O8P (664.4104)

[1-[(Z)-hexadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C37H61O8P (664.4104)

[1-decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-octadec-9-enoate

C34H65O10P (664.4315)

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] pentadecanoate

C34H65O10P (664.4315)

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropyl] (9Z,12Z)-octadeca-9,12-dienoate

C37H61O8P (664.4104)

[1-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-phosphonooxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C37H61O8P (664.4104)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-pentadec-9-enoate

C34H65O10P (664.4315)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-heptadec-9-enoate

C34H65O10P (664.4315)

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] tetradecanoate

C34H65O10P (664.4315)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (Z)-hexadec-9-enoate

C34H65O10P (664.4315)

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C37H61O8P (664.4104)

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-phosphonooxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C37H61O8P (664.4104)

[1-[(E)-dodec-5-enoyl]oxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C37H60O10 (664.4186)

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

C37H61O8P (664.4104)

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (E)-octadec-13-enoate

C34H65O10P (664.4315)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (E)-hexadec-7-enoate

C34H65O10P (664.4315)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (E)-heptadec-9-enoate

C34H65O10P (664.4315)

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] octadec-17-enoate

C34H65O10P (664.4315)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

C37H61O8P (664.4104)

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (E)-octadec-9-enoate

C34H65O10P (664.4315)

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

C37H61O8P (664.4104)

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (10E,12E)-octadeca-10,12-dienoate

C37H61O8P (664.4104)

[1-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C37H60O10 (664.4186)

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (E)-octadec-11-enoate

C34H65O10P (664.4315)

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (E)-octadec-6-enoate

C34H65O10P (664.4315)

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] octadec-17-enoate

C34H65O10P (664.4315)

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (E)-octadec-11-enoate

C37H61O8P (664.4104)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-dodecanoyloxypropyl] (E)-hexadec-9-enoate

C34H65O10P (664.4315)

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (E)-octadec-4-enoate

C34H65O10P (664.4315)

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (11E,13E,15E)-octadeca-11,13,15-trienoate

C37H61O8P (664.4104)

[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-phosphonooxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C37H61O8P (664.4104)

2-[[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H59NO8P+ (664.3978)

2-[[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H59NO8P+ (664.3978)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-dodecanoyloxypropyl] (E)-hexadec-7-enoate

C34H65O10P (664.4315)

[1-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C37H60O10 (664.4186)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] tetradecanoate

C34H65O10P (664.4315)

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (E)-octadec-7-enoate

C34H65O10P (664.4315)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-tridecanoyloxypropyl] (E)-pentadec-9-enoate

C34H65O10P (664.4315)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (E)-pentadec-9-enoate

C34H65O10P (664.4315)

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (E)-octadec-7-enoate

C34H65O10P (664.4315)

[1-dodecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C37H60O10 (664.4186)

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (E)-octadec-11-enoate

C34H65O10P (664.4315)

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (E)-octadec-13-enoate

C34H65O10P (664.4315)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-heptadec-9-enoate

C34H65O10P (664.4315)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] tetradecanoate

C34H65O10P (664.4315)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (E)-hexadec-9-enoate

C34H65O10P (664.4315)

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (E)-octadec-6-enoate

C34H65O10P (664.4315)

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (E)-octadec-4-enoate

C34H65O10P (664.4315)

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (E)-octadec-9-enoate

C34H65O10P (664.4315)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

C37H61O8P (664.4104)

2-[[3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C37H63NO7P+ (664.4342)

Medicagenic acid-3-O-glucopyranoside

C36H56O11 (664.3822)

FAHFA 21:7/O-24:7

C45H60O4 (664.4491)

FAHFA 22:7/O-23:7

C45H60O4 (664.4491)

FAHFA 23:7/O-22:7

C45H60O4 (664.4491)

FAHFA 24:7/O-21:7

C45H60O4 (664.4491)

MGDG O-28:6;O

C37H60O10 (664.4186)

MGDG O-29:5

C38H64O9 (664.455)

DGMG 17:2

C32H56O14 (664.367)

MGMG 29:5

C38H64O9 (664.455)

SQMG 24:2

C33H60O11S (664.3856)

DGGA 27:5

C36H56O11 (664.3822)

MGGA 28:5

C37H60O10 (664.4186)

PA 18:0/12:2;O3

C33H61O11P (664.3951)

PA 20:4/13:3;O

C36H57O9P (664.374)

PA 22:0/8:2;O3

C33H61O11P (664.3951)

PA 22:0/9:1;O2

C34H65O10P (664.4315)

PA 22:5/11:2;O

C36H57O9P (664.374)

PA 30:2;O3

C33H61O11P (664.3951)

PA 31:1;O2

C34H65O10P (664.4315)

PA 33:7;O

C36H57O9P (664.374)

PA 12:0_22:6

C37H61O8P (664.4104)

PA 14:1_20:5

C37H61O8P (664.4104)

PG O-20:0/7:3;O2

C33H61O11P (664.3951)

PG O-27:3;O2

C33H61O11P (664.3951)

PG O-28:2;O

C34H65O10P (664.4315)

PG P-18:1/9:1;O2

C33H61O11P (664.3951)

PG P-20:0/7:2;O2

C33H61O11P (664.3951)

PG P-20:0/8:1;O

C34H65O10P (664.4315)

PG 16:0/11:2;O

C33H61O11P (664.3951)

PG 18:1/9:1;O

C33H61O11P (664.3951)

PG 22:1/5:1;O

C33H61O11P (664.3951)

PG 10:0_18:1

C34H65O10P (664.4315)

PG 11:0_17:1

C34H65O10P (664.4315)

PG 12:0_16:1

C34H65O10P (664.4315)

PG 13:0_15:1

C34H65O10P (664.4315)

PG 14:0_14:1

C34H65O10P (664.4315)

PG 24:0/4:1

C34H65O10P (664.4315)

PG 24:1/4:0

C34H65O10P (664.4315)

PG 26:1/2:0

C34H65O10P (664.4315)

LPEth 33:6

C38H65O7P (664.4468)

LPM 34:6

C38H65O7P (664.4468)

PEth 31:7;O

C36H57O9P (664.374)

PEth 32:6

C37H61O8P (664.4104)

PM 32:7;O

C36H57O9P (664.374)

PM 33:6

C37H61O8P (664.4104)

CerPE 15:1;O2/20:5

C37H65N2O6P (664.458)

CerPE 15:2;O2/20:4

C37H65N2O6P (664.458)

CerPE 17:2;O2/18:4

C37H65N2O6P (664.458)

CerPE 35:6;O2

C37H65N2O6P (664.458)

SM 14:2;O2/18:4

C37H65N2O6P (664.458)

SM 32:6;O2

C37H65N2O6P (664.458)

SM 8:0;O2/24:6

C37H65N2O6P (664.458)

methyl 3-[(3s,3ar,4r,5ar,6s,7s,9ar,9br)-3-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

C38H64O9 (664.455)

(1r,2r,3as,3bs,8s,9ar,9br,11ar)-1-[(2s,5z)-2,7-dihydroxy-6-methylhept-5-en-2-yl]-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H56O11 (664.3822)

(1r,2r,3as,3bs,8s,9ar,9br,11ar)-1-[(2r,3s)-2,3-dihydroxy-6-methylhept-5-en-2-yl]-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H56O11 (664.3822)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 9-formyl-1,10,11-trihydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H56O11 (664.3822)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9s,10s,11r,12as,12br,14bs)-9-formyl-1,10,11-trihydroxy-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H56O11 (664.3822)

2-(3,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl)-6-methyl-5-methylideneheptanoic acid

C37H60O10 (664.4186)

(2r,3s,4r,5s)-2-{[(1r,3s,6r,9r,11r,12r,14r,15s,16s)-9,14-dihydroxy-15-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C37H60O10 (664.4186)

10,11-dihydroxy-9-({[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}methyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C40H56O8 (664.3975)

(1r,3as,5ar,7s,9as,11ar)-1-[(2r,5s)-5-hydroxy-5,6,6-trimethylheptan-2-yl]-6,6,9a,11a-tetramethyl-7-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3a-carboxylic acid

C38H64O9 (664.455)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9s,10r,11r,12as,12br,14bs)-9-formyl-1,10,11-trihydroxy-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H56O11 (664.3822)

10-(benzoyloxy)-1,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-hexadecahydropicene-4-carbonyl benzoate

C44H56O5 (664.4128)

(3as,5ar,7s,9as,11ar)-1-[(2r)-5-hydroxy-5,6,6-trimethylheptan-2-yl]-6,6,9a,11a-tetramethyl-7-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3a-carboxylic acid

C38H64O9 (664.455)

(2s,3s,4s,5r,6r)-6-{[(3s,4r,4ar,6ar,6bs,8r,8ar,12as,14ar,14br)-8a-carboxy-8-hydroxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H56O11 (664.3822)

n-[(1r,5r,6r,7s,8r,11r,12s,14r,15s,16r)-5,14-bis(acetyloxy)-7-[(acetyloxy)methyl]-15-[(1s)-1-(dimethylamino)ethyl]-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadec-3-en-6-yl]benzenecarboximidic acid

C39H56N2O7 (664.4087)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9s,10s,11r,12ar,12br,14bs)-9-formyl-1,10,11-trihydroxy-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H56O11 (664.3822)

(3s,4s,4ar,6ar,6bs,8r,8ar,12as,14ar,14br)-3,8-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

28-o-β-d-glucopyranosyl-2α-3β-dihydroxy-olean-12-ene-24,28-dioicacid

C36H56O11 (664.3822)

{"Ingredient_id": "HBIN005075","Ingredient_name": "28-o-\u03b2-d-glucopyranosyl-2\u03b1-3\u03b2-dihydroxy-olean-12-ene-24,28-dioicacid","Alias": "NA","Ingredient_formula": "C36H56O11","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C(=O)O)O)O)C)C)C2C1)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15614","TCMID_id": "8620","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3,16-dihydroxy-12-oleanene-23,28-dioic acid; (3β,16α)-form,28-o-beta-d-glucopyranosyl ester

C36H56O11 (664.3822)

{"Ingredient_id": "HBIN006951","Ingredient_name": "3,16-dihydroxy-12-oleanene-23,28-dioic acid; (3\u03b2,16\u03b1)-form,28-o-beta-d-glucopyranosyl ester","Alias": "NA","Ingredient_formula": "C36H56O11","Ingredient_Smile": "NA","Ingredient_weight": "664.82","OB_score": "NA","CAS_id": "94388-68-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8436","PubChem_id": "NA","DrugBank_id": "NA"}

beesioside f

C37H60O10 (664.4186)

{"Ingredient_id": "HBIN017680","Ingredient_name": "beesioside f","Alias": "NA","Ingredient_formula": "C37H60O10","Ingredient_Smile": "CC(=O)OC1CC2(C3CCC4C(C(CCC45C3(C5)CC(C2(C1C6(CCC(O6)C(C)(C)O)C)C)O)OC7C(C(C(CO7)O)O)O)(C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2197","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

beesioside m

C37H60O10 (664.4186)

{"Ingredient_id": "HBIN017689","Ingredient_name": "beesioside m","Alias": "NA","Ingredient_formula": "C37H60O10","Ingredient_Smile": "CC(=O)OC1C(C(C2(C1(C3CCC4C(C(CCC45C3(C5)CC2)OC6C(C(C(CO6)O)O)O)(C)C)C)C)C7(CCC(O7)C(C)(C)O)C)O","Ingredient_weight": "664.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2206","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11966777","DrugBank_id": "NA"}

9a,11a-dimethyl-1-(5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl)-dodecahydrocyclopenta[a]phenanthren-3,3a,3b,4,5,5a,6,7-octol

C32H56O14 (664.367)

(2s,3r,4s,5r)-2-{[(1s,3r,6s,8r,9s,11s,12s,14s,15r,16r)-9,14-dihydroxy-15-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C37H60O10 (664.4186)

3-(acetyloxy)-2-{[7,10-dihydroxy-1-(3-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-5-hydroxy-6-methyloxan-4-yl acetate

C37H60O10 (664.4186)

(5r)-3-[(1e)-2-[(1r,4as,5r,6r,8ar)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethenyl]-5-[(1s)-2-[(1r,4as,5r,6r,8as)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-(2-oxo-5h-furan-3-yl)ethyl]-5h-furan-2-one

C40H56O8 (664.3975)

(3s,4r,4ar,6ar,6bs,8as,11s,12r,12as,14ar,14br)-3,12-dihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

(2r,3r,4r,5s,6s)-2-{[(1s,2s,3as,3bs,7s,9ar,9bs,10r,11as)-7,10-dihydroxy-1-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-4-(acetyloxy)-5-hydroxy-6-methyloxan-3-yl acetate

C37H60O10 (664.4186)

(2r,3r,4s,5s,6r)-2-{[(1s,4s,5s,7s,8r,9r,12s,16r,17r)-16,17-dihydroxy-8-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-5,9,18,18-tetramethyl-19-oxapentacyclo[10.6.1.0¹,¹⁴.0⁴,¹².0⁵,⁹]nonadeca-2,14-dien-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H56O11 (664.3822)

(1s,2s,4r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-(benzoyloxy)-1,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-hexadecahydropicene-4-carbonyl benzoate

C44H56O5 (664.4128)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 9-formyl-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H56O11 (664.3822)

1-(5-hydroxy-5,6,6-trimethylheptan-2-yl)-6,6,9a,11a-tetramethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3a-carboxylic acid

C38H64O9 (664.455)

(5s)-3-[(1e)-2-[(1r,4as,5r,6r,8ar)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethenyl]-5-{2-[(1r,4as,5r,6r,8as)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-(2-oxo-5h-furan-3-yl)ethyl}-5h-furan-2-one

C40H56O8 (664.3975)

(2r)-2-[(1r,3s,3ar,4r,7s,9as,11ar)-3,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C37H60O10 (664.4186)

(2s,3r,4s,5s,6r)-2-[(1s)-1-[(3r,4as,6as,8r,10ar,10bs)-3,4a,7,7,10a-pentamethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-3-yl]-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C32H56O14 (664.367)

(2s,3r,6ar,6bs,8as,12ar,14ar,14br)-2-hydroxy-4,6a,6b,11,11,14b-hexamethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylic acid

C36H56O11 (664.3822)

(3s,4r,4ar,6ar,6bs,8as,11r,12r,12as,14ar,14br)-3,12-dihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

n-(5-{[3-({4-[(2-amino-5-carbamimidamido-1-hydroxypentylidene)amino]butyl}amino)-1-hydroxypropylidene]amino}pentyl)-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

C30H52N10O7 (664.402)

3-hydroxy-11-(hydroxymethyl)-4,6a,6b,11,14b-pentamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

n-[5,14-bis(acetyloxy)-7-[(acetyloxy)methyl]-15-[1-(dimethylamino)ethyl]-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadec-3-en-6-yl]benzenecarboximidic acid

C39H56N2O7 (664.4087)

2-hydroxy-1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,6,6,9b,11a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H56O11 (664.3822)

(2s,3r,4s,4ar,6ar,6bs,8as,12as,14ar,14br)-2-hydroxy-4,6a,6b,11,11,14b-hexamethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylic acid

C36H56O11 (664.3822)

(2s,3r,4s,4ar,6ar,6bs,8as,12ar,14ar,14br)-2-hydroxy-4,6a,6b,11,11,14b-hexamethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylic acid

C36H56O11 (664.3822)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-9-formyl-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H56O11 (664.3822)

bisandrographolide

C40H56O8 (664.3975)

{4-[(9e,11e,13e,15e,17e)-18-(4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl}oxidanesulfonic acid

C40H56O6S (664.3797)

(1r,2r,3r,3ar,4s,5ar,6s,7s,8s,10ar,10bs)-4,7-bis(acetyloxy)-3,6-bis(butanoyloxy)-8-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C36H56O11 (664.3822)

2-({9,14-dihydroxy-15-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate

C37H60O10 (664.4186)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C37H60O10 (664.4186)

2-({16,17-dihydroxy-8-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-5,9,18,18-tetramethyl-19-oxapentacyclo[10.6.1.0¹,¹⁴.0⁴,¹².0⁵,⁹]nonadeca-2,14-dien-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C36H56O11 (664.3822)

6-{[8a-carboxy-2-hydroxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H56O11 (664.3822)

4-[7-({5-[(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-4-hydroxy-6-methyloxan-2-yl}oxy)-3a-hydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]-5h-furan-2-one

C36H56O11 (664.3822)

(3s,4s,4ar,6ar,6bs,8as,11r,12r,12as,14ar,14br)-3,12-dihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

(1s,2r,4as,6as,6br,8ar,9s,10s,11r,12ar,12br,14bs)-10,11-dihydroxy-9-({[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}methyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C40H56O8 (664.3975)

2,3-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

3-hydroxy-11-(hydroxymethyl)-4,6a,6b,11,14b-pentamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

2-[1-(3,4a,7,7,10a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-3-yl)-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C32H56O14 (664.367)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 9-formyl-1,10,11-trihydroxy-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H56O11 (664.3822)

4,5-dihydroxy-2-{[10-hydroxy-1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxan-3-yl acetate

C38H64O9 (664.455)

2-[2-(3,4a,7,7,10a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-3-yl)-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C32H56O14 (664.367)

(1r,2r,3r,3ar,4s,5ar,6s,7s,8s,10as,10br)-6,7-bis(acetyloxy)-3,4-bis(butanoyloxy)-8-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C36H56O11 (664.3822)

3,8-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

(2s,3s,4s,5r,6r)-6-{[(3s,4r,4ar,6ar,6bs,8ar,12s,12as,14ar,14br)-8a-carboxy-12-hydroxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H56O11 (664.3822)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,4ar,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-9-formyl-1,10,11-trihydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H56O11 (664.3822)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2s,4as,6as,6br,8ar,9s,10r,11r,12ar,12br,14bs)-9-formyl-1,10,11-trihydroxy-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H56O11 (664.3822)

(1r,3s,3ar,3br,4s,5s,5as,6s,7s,9ar,9br,11ar)-9a,11a-dimethyl-1-[(2r,5r)-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-dodecahydrocyclopenta[a]phenanthren-3,3a,3b,4,5,5a,6,7-octol

C32H56O14 (664.367)

(2r,3r,4s,5s,6r)-2-[(2s)-2-[(3r,4as,6as,8r,10ar,10bs)-3,4a,7,7,10a-pentamethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-3-yl]-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C32H56O14 (664.367)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-9-formyl-1,10,11-trihydroxy-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H56O11 (664.3822)

(1r,2r,3r,3ar,4s,5ar,6s,7s,8s,10as,10br)-3,7-bis(acetyloxy)-6-(butanoyloxy)-8-hydroxy-1-isopropyl-3a,5a,9-trimethyl-2-[(2-methylpropanoyl)oxy]-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-4-yl butanoate

C36H56O11 (664.3822)

5-{2-[6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-(2-oxo-5h-furan-3-yl)ethyl}-3-{2-[6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethenyl}-5h-furan-2-one

C40H56O8 (664.3975)

(2s,3s,4s,5r,6r)-6-{[(2s,3r,4r,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-carboxy-2-hydroxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H56O11 (664.3822)

(1s,3r,6s,8r,11r,12s,13r,14r,15r,16r)-14-hydroxy-15-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-13-yl acetate

C37H60O10 (664.4186)

[(1r,2r,5r,8r,9r,10s,13r,14r,15r,17s,18s)-17-hydroxy-1,2,6,6,9-pentamethyl-15-(prop-1-en-2-yl)-18-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-7-oxapentacyclo[11.7.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁸]icosan-8-yl]acetic acid

C36H56O11 (664.3822)

6-{[8a-carboxy-12-hydroxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H56O11 (664.3822)

(2r,3r,4r,5s,6s)-2-{[(1r,2s,3as,3bs,7s,9ar,9bs,10r,11as)-7,10-dihydroxy-1-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-4-(acetyloxy)-5-hydroxy-6-methyloxan-3-yl acetate

C37H60O10 (664.4186)

(2r,3r,4r,4ar,6ar,6bs,8as,12as,14ar,14br)-2,3-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

(2s,4ar,6as,6br,8ar,9r,10r,11s,12ar,12br)-11-hydroxy-9-(hydroxymethyl)-2-(methoxycarbonyl)-2,6a,6b,9,12a-pentamethyl-10-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H56O11 (664.3822)

(1r,3as,5ar,7s,9as,11ar)-1-[(2r,5r)-5-hydroxy-5,6,6-trimethylheptan-2-yl]-6,6,9a,11a-tetramethyl-7-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3a-carboxylic acid

C38H64O9 (664.455)

(1r,2r,3as,3bs,8s,9ar,9br,11ar)-2-hydroxy-1-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H56O11 (664.3822)

1-(2,7-dihydroxy-6-methylhept-5-en-2-yl)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H56O11 (664.3822)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2s,3r,4s)-4-methyl-5-oxo-2-(14-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentadecyl)oxolane-3-carboxylate

C32H56O14 (664.367)

methyl 3-[3-(2-hydroxy-6-methyl-5-methylideneheptan-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

C38H64O9 (664.455)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2r,4as,6as,6br,8r,8ar,9r,10r,11r,12ar,12br,14bs)-8,10,11-trihydroxy-9-(hydroxymethyl)-2,6a,6b,9,12a-pentamethyl-1-methylidene-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H56O11 (664.3822)

5-[6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-1-[2-(2-oxo-5h-furan-3-yl)ethyl]-hexahydronaphthalen-1-yl]-3-[(1e)-2-[6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethenyl]-5h-furan-2-one

C40H56O8 (664.3975)

(2r,3r,4s,5r,6r)-2-{[(1s,2r,3s,4r,7r,9s,12r,14s,17r,18r,19r,21r,22s)-2-hydroxy-22-(2-methoxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C37H60O10 (664.4186)

14-hydroxy-15-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-13-yl acetate

C37H60O10 (664.4186)

2-{[2-hydroxy-22-(2-methoxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C37H60O10 (664.4186)

3,12-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

3,4,5-trihydroxy-6-(methoxymethyl)oxan-2-yl 1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C37H60O10 (664.4186)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9s,10r,11r,12ar,12br,14bs)-9-formyl-1,10,11-trihydroxy-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H56O11 (664.3822)

(2s,3r,4r,5r,6s)-2-{[(4e,6z,8z,10e,12e,14e,16z,18z,20e)-2-hydroxy-21-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-2,6,10,15,19-pentamethylhenicosa-4,6,8,10,12,14,16,18,20-nonaen-3-yl]oxy}-6-methyloxane-3,4,5-triol

C41H60O7 (664.4339)

(3e,5e,7e,9e,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-15,31-dimethyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C37H60O10 (664.4186)

(2s,4ar,6as,6br,8ar,9r,10r,11s,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-2-(methoxycarbonyl)-2,6a,6b,9,12a-pentamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H56O11 (664.3822)

(3s,4r,4ar,6ar,6bs,8ar,11r,12as,14ar,14br)-3-hydroxy-11-(hydroxymethyl)-4,6a,6b,11,14b-pentamethyl-8a-({[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8r,8ar,9r,10r,11r,12ar,12br,14bs)-8,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-4,5,6,7,8,8a,10,11,12,12b,13,14b-dodecahydro-3h-picene-4a-carboxylate

C36H56O11 (664.3822)

(1r,2r,3r,3ar,4s,5ar,6s,7s,8s,10ar,10bs)-6,7-bis(acetyloxy)-3,4-bis(butanoyloxy)-8-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C36H56O11 (664.3822)

(1s,3r,6s,8r,11r,12s,13r,14r,15r,16r)-14-hydroxy-15-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-13-yl acetate

C37H60O10 (664.4186)

(2r)-2-[(1r,3s,3ar,4r,5ar,7s,9as,11ar)-3,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C37H60O10 (664.4186)

(3r,4s,4ar,6ar,6bs,8as,11s,12r,12as,14ar,14br)-3,12-dihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

(3z,5z,7z,9z,11z,14s,15s,16r,18r,20r,24s,26r,28r,29z,31s,32s)-32-[(2s)-butan-2-yl]-14,16,18,20,22,24,26,28-octahydroxy-15,31-dimethyl-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C37H60O10 (664.4186)

(3z,5z,7z,9z,11z,29z)-14,16,18,20,22,24,26,28-octahydroxy-15,31-dimethyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C37H60O10 (664.4186)

(5s)-5-[(1s)-2-[(1s,4ar,5s,6r,8as)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-(4-oxo-5h-furan-3-yl)ethyl]-3-[(1e)-2-[(1s,4as,5r,6r,8as)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethenyl]-5h-furan-2-one

C40H56O8 (664.3975)

1-(2,3-dihydroxy-6-methylhept-5-en-2-yl)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H56O11 (664.3822)

(2r)-2-[(1r,3s,3ar,4r,5as,7s,9as,11ar)-3,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C37H60O10 (664.4186)

(3s,4r,4ar,6ar,6bs,8ar,12s,12as,14ar,14br)-3,12-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-8a-({[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

2-({15-[4-hydroxy-2-methoxy-5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C37H60O10 (664.4186)

3,12-dihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O11 (664.3822)

(2s)-n-[5-({3-[(4-{[(2s)-2-amino-5-carbamimidamido-1-hydroxypentylidene]amino}butyl)amino]-1-hydroxypropylidene}amino)pentyl]-2-{[2-(2,4-dihydroxyphenyl)-1-hydroxyethylidene]amino}butanediimidic acid

C30H52N10O7 (664.402)

(1r,2r,3r,3ar,4s,5ar,6s,7s,8s,10ar,10bs)-3,7-bis(acetyloxy)-4,6-bis(butanoyloxy)-8-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C36H56O11 (664.3822)

(1r,2r,3r,3ar,4s,5ar,6s,7s,8s,10as,10br)-4,7-bis(acetyloxy)-3,6-bis(butanoyloxy)-8-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C36H56O11 (664.3822)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2r,4as,6as,6br,8r,8ar,9r,10r,11r,12ar,12br)-8,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-3,4,5,6,7,8,8a,10,11,12,12b,13-dodecahydro-2h-picene-4a-carboxylate

C36H56O11 (664.3822)

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5as,7s,9as,9br,10r,11ar)-10-hydroxy-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl acetate

C38H64O9 (664.455)

(2r,3r,4s,5s,6r)-2-{[(1s,3r,6s,7s,8r,11r,12s,15r,16r)-15-[(2r,3s,4s,5r)-4-hydroxy-2-methoxy-5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C37H60O10 (664.4186)

(1r,3r,3ar,4s,5ar,6s,7s,8s,10as,10br)-4,7-bis(acetyloxy)-2,6-bis(butanoyloxy)-8-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-3-yl butanoate

C36H56O11 (664.3822)